Neumora Therapeutics Inc (NMRA)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -56.86M | -114M | -60.07M |
| Pre Tax Income | -53.03M | -108.46M | -53.72M |
| Net Income | -53.03M | -108.73M | -53.72M |
| Preferred Dividends | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 |
| EBIT | -56.87M | -114.11M | -60.09M |
| EBITDA | -56.69M | -113.84M | -59.92M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -237.32M | -135.87M | -252.1M |
| Pre Tax Income | -237.31M | -130.9M | -235.66M |
| Net Income | -237.31M | -130.9M | -235.93M |
| Preferred Dividends | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.239 | -0.256 | -0.575 |
| EBIT | -237.31M | -135.47M | -252.27M |
| EBITDA | -236.79M | -135.28M | -251.43M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
